Jing Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jing Chen has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Yincheng Teng
Department of Obstetrics and Gynecology, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
4 shared publications Yanli Xu
Department of Obstetrics and Gynecology, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
3 shared publications- Bikang Yang
Department of Gynecologic Oncology Ward 5, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan 410013, China
2 shared publications - Li Ma
Department of Obstetrics and Gynecology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
2 shared publications Qinyang Xu
Department of Obstetrics and Gynecology, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
2 shared publicationsYu Li
Department of Obstetrics and Gynecology, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
2 shared publications
Latest Publications
- Open Access
- 15 September 2026
- Published by Springer Nature in BMC Women's Health
Efficacy and safety of 5-aminolevulinic acid-mediated photodynamic therapy versus loop electrosurgical excision procedure for cervical high-grade squamous intraepithelial lesions: a prospective non-randomized controlled clinical study
Background: Excisional procedures represent the standard of care for cervical high-grade squamous intraepithelial lesions (HSIL), but they may affect the integrity of the cervix and fertility. This prospective, non-randomized controlled clinical study evaluated the efficacy and safety of 5-aminolevulinic acid-mediated photodynamic therapy (5-ALA PDT) compared with the loop electrosurgical excision procedure (LEEP) and explored the associated immunomodulatory changes in the local cervical microenvironment. Methods: Between June 2023 and December 2024, a total of 123 women with cervical HSIL were enrolled. Based on patient preference, 63 participants received 5-ALA PDT and 60 participants underwent LEEP. Follow-up assessments were performed at 3 and 6 months. Cervical cytokine profiling was conducted at both time points, whereas standardized clinical efficacy evaluation, including cytology, HR-HPV DNA testing, HPV E6/E7 mRNA detection, colposcopy, and histopathological assessment, was performed at the 6-month endpoint. Adverse events were graded using CTCAE version 5.0. Firth penalized logistic regression, adjusted marginal absolute risk differences, and generalized estimating equations were used. Results: At 6 months, complete histopathological remission was 87.3% after 5-ALA PDT and 95.0% after LEEP ( P = 0.135); HR-HPV clearance was 74.6% and 86.7% ( P = 0.092). After adjustment, LEEP showed higher odds of complete remission (adjusted OR = 18.619, 95% CI 1.573–220.412; P = 0.020), with substantial imprecision; the marginal ARD was 21.9% points (95% bootstrap CI 7.0–35.7). The treatment association for HR-HPV clearance was non-significant (adjusted OR = 3.406, 95% CI 0.778–14.914; P = 0.104; marginal ARD = 16.5% points, 95% bootstrap CI − 2.3 to 36.3). HPV16/18 positivity was associated with lower clearance odds. Seven cytokines showed significant group-by-time interactions after FDR correction, but none was associated with HR-HPV clearance. Neither group had CTCAE Grade ≥ 3 adverse events. Conclusions: 5-ALA PDT showed promising short-term histopathological and virological activity in selected patients, and both had favorable short-term safety. LEEP was associated with higher adjusted odds of complete remission, but HR-HPV clearance did not differ significantly. Given non-randomization, baseline imbalance, no prespecified non-inferiority margin, and 6-month follow-up, equivalence or non-inferiority cannot be concluded. Cytokine findings were exploratory. Larger randomized trials should assess longer-term durability, recurrence, reproductive outcomes, and cytokine findings. Trial registration: Chinese Clinical Trial Registry, ChiCTR2300071897. The Registration Date: Registered on 29 May 2023.
- 15 September 2026
- Published by Springer Nature in BMC Women's Health
Open AccessEfficacy and safety of 5-aminolevulinic acid-mediated photodynamic therapy versus loop electrosurgical excision procedure for cervical high-grade squamous intraepithelial lesions: a prospective non-randomized controlled clinical study
Background: Excisional procedures represent the standard of care for cervical high-grade squamous intraepithelial lesions (HSIL), but they may affect the integrity of the cervix and fertility. This prospective, non-randomized controlled clinical study evaluated the efficacy and safety of 5-aminolevulinic acid-mediated photodynamic therapy (5-ALA PDT) compared with the loop electrosurgical excision procedure (LEEP) and explored the associated immunomodulatory changes in the local cervical microenvironment. Methods: Between June 2023 and December 2024, a total of 123 women with cervical HSIL were enrolled. Based on patient preference, 63 participants received 5-ALA PDT and 60 participants underwent LEEP. Follow-up assessments were performed at 3 and 6 months. Cervical cytokine profiling was conducted at both time points, whereas standardized clinical efficacy evaluation, including cytology, HR-HPV DNA testing, HPV E6/E7 mRNA detection, colposcopy, and histopathological assessment, was performed at the 6-month endpoint. Adverse events were graded using CTCAE version 5.0. Firth penalized logistic regression, adjusted marginal absolute risk differences, and generalized estimating equations were used. Results: At 6 months, complete histopathological remission was 87.3% after 5-ALA PDT and 95.0% after LEEP ( P = 0.135); HR-HPV clearance was 74.6% and 86.7% ( P = 0.092). After adjustment, LEEP showed higher odds of complete remission (adjusted OR = 18.619, 95% CI 1.573–220.412; P = 0.020), with substantial imprecision; the marginal ARD was 21.9% points (95% bootstrap CI 7.0–35.7). The treatment association for HR-HPV clearance was non-significant (adjusted OR = 3.406, 95% CI 0.778–14.914; P = 0.104; marginal ARD = 16.5% points, 95% bootstrap CI − 2.3 to 36.3). HPV16/18 positivity was associated with lower clearance odds. Seven cytokines showed significant group-by-time interactions after FDR correction, but none was associated with HR-HPV clearance. Neither group had CTCAE Grade ≥ 3 adverse events. Conclusions: 5-ALA PDT showed promising short-term histopathological and virological activity in selected patients, and both had favorable short-term safety. LEEP was associated with higher adjusted odds of complete remission, but HR-HPV clearance did not differ significantly. Given non-randomization, baseline imbalance, no prespecified non-inferiority margin, and 6-month follow-up, equivalence or non-inferiority cannot be concluded. Cytokine findings were exploratory. Larger randomized trials should assess longer-term durability, recurrence, reproductive outcomes, and cytokine findings. Trial registration: Chinese Clinical Trial Registry, ChiCTR2300071897. The Registration Date: Registered on 29 May 2023.
- 30 November 2023
- Published by Elsevier in Experimental Cell Research
- Vol. 434 (1) , 113866
IRX2 regulates endometrial carcinoma oncogenesis by transcriptional repressing RUVBL1
- 30 November 2023
- Published by Elsevier in Experimental Cell Research
- Vol. 434 (1) , 113866
IRX2 regulates endometrial carcinoma oncogenesis by transcriptional repressing RUVBL1
- Open Access
- 20 September 2023
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 11, 1109710
Transcriptome analyses reveal new insights on key determinants of perineural invasion in high-grade serous ovarian cancer
Perineural invasion (PNI) is a pathological feature of many cancers associated with poor outcomes, metastases, and recurrence. In relation to ovarian cancer (OC), there is no information about PNI’s role and mechanisms. Our study found that patients with PNI-positive symptoms had significantly shorter overall survival (OS) time than patients with PNI-negative symptoms. Multivariate analyses demonstrated that PNI represented a substantial independent prognostic factor in OC patients. At the transcriptome level, it is noteworthy that PNI positivity was negatively correlated with the degree of infiltration of immune killer cells in OC tumor tissues, including macrophage, central memory CD4 T-cell, natural killer cells, monocyte, and central memory CD4 T-cell. The results of this study revealed that TAS2Rs proteins were markedly upregulated in PNI-positive OC tissues and predicted poor prognoses. Moreover, Immunohistochemical analysis demonstrated that the TAS2R10 protein was associated with poor prognoses and PNI in OC. Consequently, we found for the first time that PNI was a powerful predictor of poor prognosis in OC and analyzed its expression pattern and some preliminary biochemical characterization, providing new clues for guiding clinical prevention and treatment of OC.
- 20 September 2023
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 11, 1109710
Open AccessTranscriptome analyses reveal new insights on key determinants of perineural invasion in high-grade serous ovarian cancer
Perineural invasion (PNI) is a pathological feature of many cancers associated with poor outcomes, metastases, and recurrence. In relation to ovarian cancer (OC), there is no information about PNI’s role and mechanisms. Our study found that patients with PNI-positive symptoms had significantly shorter overall survival (OS) time than patients with PNI-negative symptoms. Multivariate analyses demonstrated that PNI represented a substantial independent prognostic factor in OC patients. At the transcriptome level, it is noteworthy that PNI positivity was negatively correlated with the degree of infiltration of immune killer cells in OC tumor tissues, including macrophage, central memory CD4 T-cell, natural killer cells, monocyte, and central memory CD4 T-cell. The results of this study revealed that TAS2Rs proteins were markedly upregulated in PNI-positive OC tissues and predicted poor prognoses. Moreover, Immunohistochemical analysis demonstrated that the TAS2R10 protein was associated with poor prognoses and PNI in OC. Consequently, we found for the first time that PNI was a powerful predictor of poor prognosis in OC and analyzed its expression pattern and some preliminary biochemical characterization, providing new clues for guiding clinical prevention and treatment of OC.
- Open Access
- 29 April 2023
- Published by Wiley in Journal of Immunology Research
- Vol. 2023, 1-13
Increased FOXM1 Expression was Associated with the Prognosis and the Recruitment of Neutrophils in Endometrial Cancer
Background. Although the biological functions of Forkhead box protein M1 (FOXM1) were explored in a variety of cancer, to date, however, little attention has been paid to the situation of FOXM1 in EC endometrial cancer (EC). Method. Bioinformatics analysis, including GEPIA, TIMER, cBioPortal, LinkedOmics, and STRING were used to analyze the FOXM1 gene expression, genetic alteration, and immune cell infiltration in EC. IHC staining, qPCR, cell viability, and migration assay were applied to identify the functions of FOXM1 in EC. Results. FOXM1 was highly expressed in EC tissues and closely correlated with the prognosis of EC patients. FOXM1 knockdown inhibited EC cell proliferation and invasion as well as migration. FOXM1 genetic alteration was verified in EC patients. Coexpression network of FOXM1 indicated that it had roles in the EC cell cycle and the infiltration of immune cells in EC. Furthermore, bioinformatic and immunohistochemical analysis indicated that FOXM1 induced the increased CD276 expression and also enhanced the neutrophil recruitment in EC. Conclusion. Our present study discovered a novel role of FOXM1 in EC, suggesting FOXM1 could be treated as a potential prognostic biomarker and immunotherapeutic target in EC diagnosis and treatment.
- 29 April 2023
- Published by Wiley in Journal of Immunology Research
- Vol. 2023, 1-13
Open AccessIncreased FOXM1 Expression was Associated with the Prognosis and the Recruitment of Neutrophils in Endometrial Cancer
Background. Although the biological functions of Forkhead box protein M1 (FOXM1) were explored in a variety of cancer, to date, however, little attention has been paid to the situation of FOXM1 in EC endometrial cancer (EC). Method. Bioinformatics analysis, including GEPIA, TIMER, cBioPortal, LinkedOmics, and STRING were used to analyze the FOXM1 gene expression, genetic alteration, and immune cell infiltration in EC. IHC staining, qPCR, cell viability, and migration assay were applied to identify the functions of FOXM1 in EC. Results. FOXM1 was highly expressed in EC tissues and closely correlated with the prognosis of EC patients. FOXM1 knockdown inhibited EC cell proliferation and invasion as well as migration. FOXM1 genetic alteration was verified in EC patients. Coexpression network of FOXM1 indicated that it had roles in the EC cell cycle and the infiltration of immune cells in EC. Furthermore, bioinformatic and immunohistochemical analysis indicated that FOXM1 induced the increased CD276 expression and also enhanced the neutrophil recruitment in EC. Conclusion. Our present study discovered a novel role of FOXM1 in EC, suggesting FOXM1 could be treated as a potential prognostic biomarker and immunotherapeutic target in EC diagnosis and treatment.
- Open Access
- 3 April 2023
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14
Loss of NLRP3 reduces oxidative stress and polarizes intratumor macrophages to attenuate immune attack on endometrial cancer
Introduction: The interaction between endometrial cancer (EMC) cells and intratumoral macrophages plays a significant role in the development of the disease. PYD domains-containing protein 3 (NLRP3) inflammasome formation triggers caspase-1/IL-1β signaling pathways and produces reactive oxygen species (ROS) in macrophages. However, the role of NLRP3-regulated ROS production in macrophage polarization and the subsequent growth and metastasis of EMC remains unknown.Methods: We conducted bioinformatic analysis to compare NLRP3 levels in intratumoral macrophages from EMC and normal endometrium. In vitro experiments involved knocking out NLRP3 in macrophages to shift the polarization from an anti-inflammatory M1-like phenotype to a proinflammatory M2-like phenotype and reduce ROS production. The impact of NLRP3 depletion on the growth, invasion, and metastasis of co-cultured EMC cells was assessed. We also evaluated the effect of NLRP3 depletion in macrophages on the growth and metastasis of implanted EMC cells in mice.Results: Our bioinformatic analysis showed significantly lower NLRP3 levels in intratumoral macrophages from EMC than those from normal endometrium. Knocking out NLRP3 in macrophages shifted their polarization to a proinflammatory M2-like phenotype and significantly reduced ROS production. NLRP3 depletion in M2-polarized macrophages increased the growth, invasion, and metastasis of co-cultured EMC cells. NLRP3 depletion in M1-polarized macrophages reduced phagocytic potential, which resulted in weakened immune defense against EMC. Additionally, NLRP3 depletion in macrophages significantly increased the growth and metastasis of implanted EMC cells in mice, likely due to compromised phagocytosis by macrophages and a reduction in cytotoxic CD8+ T cells.Discussion: Our results suggest that NLRP3 plays a significant role in regulating macrophage polarization, oxidative stress, and immune response against EMC. NLRP3 depletion alters the polarization of intratumoral macrophages, leading to weakened immune defense against EMC cells. The reduction in ROS production by the loss of NLRP3 may have implications for the development of novel treatment strategies for EMC.
- 3 April 2023
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14
Open AccessLoss of NLRP3 reduces oxidative stress and polarizes intratumor macrophages to attenuate immune attack on endometrial cancer
Introduction: The interaction between endometrial cancer (EMC) cells and intratumoral macrophages plays a significant role in the development of the disease. PYD domains-containing protein 3 (NLRP3) inflammasome formation triggers caspase-1/IL-1β signaling pathways and produces reactive oxygen species (ROS) in macrophages. However, the role of NLRP3-regulated ROS production in macrophage polarization and the subsequent growth and metastasis of EMC remains unknown.Methods: We conducted bioinformatic analysis to compare NLRP3 levels in intratumoral macrophages from EMC and normal endometrium. In vitro experiments involved knocking out NLRP3 in macrophages to shift the polarization from an anti-inflammatory M1-like phenotype to a proinflammatory M2-like phenotype and reduce ROS production. The impact of NLRP3 depletion on the growth, invasion, and metastasis of co-cultured EMC cells was assessed. We also evaluated the effect of NLRP3 depletion in macrophages on the growth and metastasis of implanted EMC cells in mice.Results: Our bioinformatic analysis showed significantly lower NLRP3 levels in intratumoral macrophages from EMC than those from normal endometrium. Knocking out NLRP3 in macrophages shifted their polarization to a proinflammatory M2-like phenotype and significantly reduced ROS production. NLRP3 depletion in M2-polarized macrophages increased the growth, invasion, and metastasis of co-cultured EMC cells. NLRP3 depletion in M1-polarized macrophages reduced phagocytic potential, which resulted in weakened immune defense against EMC. Additionally, NLRP3 depletion in macrophages significantly increased the growth and metastasis of implanted EMC cells in mice, likely due to compromised phagocytosis by macrophages and a reduction in cytotoxic CD8+ T cells.Discussion: Our results suggest that NLRP3 plays a significant role in regulating macrophage polarization, oxidative stress, and immune response against EMC. NLRP3 depletion alters the polarization of intratumoral macrophages, leading to weakened immune defense against EMC cells. The reduction in ROS production by the loss of NLRP3 may have implications for the development of novel treatment strategies for EMC.
- Open Access
- 26 July 2022
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 39, 103037
Topical 5-aminolevulinic acid photodynamic therapy for cervical high-grade squamous intraepithelial lesions
- 26 July 2022
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 39, 103037
Open AccessTopical 5-aminolevulinic acid photodynamic therapy for cervical high-grade squamous intraepithelial lesions
- 1 February 2022
- Published by Elsevier in Composite Structures
- Vol. 281, 114980
Study on formability and failure modes of steel/CFRP based FMLs consisting of carbon fiber reinforced polymer prepreg and steel sheet
- 1 February 2022
- Published by Elsevier in Composite Structures
- Vol. 281, 114980
Study on formability and failure modes of steel/CFRP based FMLs consisting of carbon fiber reinforced polymer prepreg and steel sheet
- Open Access
- 24 April 2021
- Published by Wiley in Journal of Immunology Research
- Vol. 2021, 1-12
TNPO1-Mediated Nuclear Import of FUBP1 Contributes to Tumor Immune Evasion by Increasing NRP1 Expression in Cervical Cancer
Far upstream element binding protein 1 (FUBP1), a DNA-binding protein, participates in diverse tumor-promoting behaviors by regulating the expression of oncogenes in the nucleus, but the underlying mechanisms remain to be elucidated. In the present study, we found that FUBP1 mRNA and protein expressions were markedly upregulated and closely linked with poor prognosis in cervical cancer. In vitro, functional experiments showed that knockdown of FUBP1 inhibited CC cell proliferation and migration. Therefore, FUBP1 plays a prooncogenic function in CC progression. Further investigations for the first time demonstrated that nuclear localization of FUBP1 regulated the gene expression of immune checkpoint NRP1. Moreover, our work demonstrated that FUBP1 translocated into the nucleus which was mediated by interacting with Transportin-1 (TNPO1). Collectively, this study revealed that FUBP1 might be a potential therapeutic target for the restriction of tumor progression.
- 24 April 2021
- Published by Wiley in Journal of Immunology Research
- Vol. 2021, 1-12
Open AccessTNPO1-Mediated Nuclear Import of FUBP1 Contributes to Tumor Immune Evasion by Increasing NRP1 Expression in Cervical Cancer
Far upstream element binding protein 1 (FUBP1), a DNA-binding protein, participates in diverse tumor-promoting behaviors by regulating the expression of oncogenes in the nucleus, but the underlying mechanisms remain to be elucidated. In the present study, we found that FUBP1 mRNA and protein expressions were markedly upregulated and closely linked with poor prognosis in cervical cancer. In vitro, functional experiments showed that knockdown of FUBP1 inhibited CC cell proliferation and migration. Therefore, FUBP1 plays a prooncogenic function in CC progression. Further investigations for the first time demonstrated that nuclear localization of FUBP1 regulated the gene expression of immune checkpoint NRP1. Moreover, our work demonstrated that FUBP1 translocated into the nucleus which was mediated by interacting with Transportin-1 (TNPO1). Collectively, this study revealed that FUBP1 might be a potential therapeutic target for the restriction of tumor progression.
- Open Access
- 11 February 2021
- Published by Wiley in Journal of Immunology Research
- Vol. 2021, 1-14
CDK12 Promotes Cervical Cancer Progression through Enhancing Macrophage Infiltration
Cervical cancer (CC) is a commonly diagnosed and primary consideration of cancer patient death in female reproductive system malignancy. Cyclin-dependent kinase 12 (CDK12), as a transcription-associated CDK, plays important roles in tumor-promoting behaviors, whereas the underlying mechanisms of CDK12 in CC progression are still obscure. In this report, we investigated the role of CDK12 in cervical cancer. The current study identified CDK12 mRNA and protein expression remarkably upregulated in CC patients. Upregulated CDK12 was closely associated with CC progression and poor prognosis. In vitro and in vivo functional experiments showed that knockdown of CDK12 inhibited cancer cell proliferation and colony formation and promoted apoptosis. Further investigations demonstrated that CDK12 regulated the immune microenvironment to facilitate the progression of CC cells by promoting macrophage infiltration. Meanwhile, we first demonstrated that nuclear import of CDK12 is mediated by TNPO1 and might be a new therapeutic target in oncology. Collectively, this study pointed out the potential of CDK12 to serve as a novel therapeutic target in restricting CC proliferation and cell cycle process through promoting macrophage infiltration.
- 11 February 2021
- Published by Wiley in Journal of Immunology Research
- Vol. 2021, 1-14
Open AccessCDK12 Promotes Cervical Cancer Progression through Enhancing Macrophage Infiltration
Cervical cancer (CC) is a commonly diagnosed and primary consideration of cancer patient death in female reproductive system malignancy. Cyclin-dependent kinase 12 (CDK12), as a transcription-associated CDK, plays important roles in tumor-promoting behaviors, whereas the underlying mechanisms of CDK12 in CC progression are still obscure. In this report, we investigated the role of CDK12 in cervical cancer. The current study identified CDK12 mRNA and protein expression remarkably upregulated in CC patients. Upregulated CDK12 was closely associated with CC progression and poor prognosis. In vitro and in vivo functional experiments showed that knockdown of CDK12 inhibited cancer cell proliferation and colony formation and promoted apoptosis. Further investigations demonstrated that CDK12 regulated the immune microenvironment to facilitate the progression of CC cells by promoting macrophage infiltration. Meanwhile, we first demonstrated that nuclear import of CDK12 is mediated by TNPO1 and might be a new therapeutic target in oncology. Collectively, this study pointed out the potential of CDK12 to serve as a novel therapeutic target in restricting CC proliferation and cell cycle process through promoting macrophage infiltration.